{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:55:04Z","timestamp":1772751304233,"version":"3.50.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>COVID-19 pandemic has spread widely at unpreceded pace. Cardiovascular comorbidities are significantly correlated with severe and critical illness. Nevertheless, studies examining the impact of congenital heart disease on COVID-19 severity are scarce and restricted to hospitalized patients. This study aims to explore the course of COVID-19 illness, severity and complications in patients with concomitant congenital heart disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>This study is a cross sectional survey that includes patients with congenital heart disease who are registered at the Children Heart Center at the American University of Beirut Medical Center. The survey was conducted in the pediatric cardiology outpatient clinics or remotely via phone calls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 238 patients participated in the study, of which 47.9% had suspected or confirmed diagnosis of SARS-CoV-2 infection. The majority of patients had mild illness. The symptoms ranged between rhinorrhea (15.6%), cough (15.6%), low-grade fever (11.2%), anosmia (2.7%), ageusia (2.5%), headache (9.8%), high-grade fever (8.5%), gastrointestinal symptoms (7.6%), lethargy (6.3%), muscle aches (5.6%), difficulty breathing (5.4%), joint pain (4.7%), and chills (4.7%). 20% of the surveyed patients required treatment at home. Hospitalization and oxygen therapy was required in 3.5% of cases, while only 1.5% demanded intensive care admission. Only one fatality was encountered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>COVID-19 infection in pateints with congenital heart disease exhibits a mild to moderate course, and doesn't necessarily increase risk of complicated disease. No correlation could be found between specific congenital heart lesion and disease severity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1235165","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T13:31:26Z","timestamp":1693488686000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19 in congenital heart disease patients: what did we learn?!"],"prefix":"10.3389","volume":"10","author":[{"given":"Rana","family":"Zareef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresia","family":"Tannouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Bitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"B1","volume-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"Cascella","year":"2022"},{"key":"B2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/thorax.58.8.686","article-title":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","volume":"58","author":"Chan","year":"2003","journal-title":"Thorax"},{"key":"B3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11239-020-02210-8","article-title":"COVID-19: are we dealing with a multisystem vasculopathy in disguise of a viral infection?","volume":"50","author":"Mondal","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/apa.15270","article-title":"Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults","volume":"109","author":"Ludvigsson","year":"2020","journal-title":"Acta Paediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1056\/NEJMoa2007621","article-title":"Cardiovascular disease, drug therapy, and mortality in COVID-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"117723","DOI":"10.1016\/j.lfs.2020.117723","article-title":"Myocardial injury and COVID-19: possible mechanisms","volume":"253","author":"Babapoor-Farrokhran","year":"2020","journal-title":"Life Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5518979","DOI":"10.1155\/2021\/5518979","article-title":"Cardiac manifestations in COVID-19 patients: a focus on the pediatric population","volume":"2021","author":"Abi Nassif","year":"2021","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1017\/S1047951114002728","article-title":"The impact of illness perceptions and disease severity on quality of life in congenital heart disease","volume":"26","author":"O\u2019Donovan","year":"2016","journal-title":"Cardiol Young"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.ijcchd.2020.100076","article-title":"Adult congenital heart disease: looking back, moving forward","volume":"2","author":"Ntiloudi","year":"2021","journal-title":"Int J Cardiol Congenital Heart Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"646780","DOI":"10.1155\/2012\/646780","article-title":"Managing the morbidity associated with respiratory viral infections in children with congenital heart disease","volume":"2012","author":"Geskey","year":"2012","journal-title":"Int J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"ehac544","DOI":"10.1093\/eurheartj\/ehac544.1848","article-title":"Adults with congenital heart disease and COVID-19","volume":"43","author":"Langes","year":"2022","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/jcm9061774","article-title":"COVID-19 and congenital heart disease: results from a nationwide survey","volume":"9","author":"Sabatino","year":"2020","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jacc.2021.02.023","article-title":"COVID-19 in adults with congenital heart disease","volume":"77","author":"Broberg","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12519-020-00397-7","article-title":"COVID-19 and congenital heart disease: a case series of nine children","volume":"17","author":"Haji Esmaeil Memar","year":"2021","journal-title":"World J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/heartjnl-2020-318467","article-title":"Clinical outcome of COVID-19 in patients with adult congenital heart disease","volume":"107","author":"Schwerzmann","year":"2021","journal-title":"Heart"},{"key":"B18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00246-021-02751-6","article-title":"Worse hospital outcomes for children and adults with COVID-19 and congenital heart disease","volume":"43","author":"Strah","year":"2022","journal-title":"Pediatr Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e017580","DOI":"10.1161\/JAHA.120.017580","article-title":"Impact of coronavirus disease 2019 (COVID-19) on patients with congenital heart disease across the lifespan: the experience of an academic congenital heart disease center in New York city","volume":"9","author":"Lewis","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4103\/apc.apc_134_21","article-title":"Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: a multicentric study from India","volume":"14","author":"Sachdeva","year":"2021","journal-title":"Ann Pediatr Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1235165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T13:31:28Z","timestamp":1693488688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1235165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":20,"alternative-id":["10.3389\/fcvm.2023.1235165"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1235165","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"article-number":"1235165"}}